Circulating Tumor DNA as a Complementary Prognostic Biomarker during CAR-T Therapy in B-Cell Non-Hodgkin Lymphomas.

Cancers (Basel) · 2024 · PMC11120115 · PMID 38791959

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

did not reach statistical significancep = 0.073so close (0.05 < p ≤ 0.1)

Lower peak GIN values trended toward predicting CR as the best response; however, they did not reach statistical significance ( p = 0.073), which may be due to insufficient power secondary to small sample size [ 76 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.